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Methods: We retrospectively analyzed patients hospitalised in our center 
with pericarditis from January 2006 to December 2010. Patients with acute 
coronary syndromes were excluded.
Results: 114 patients were included. Mean age was 57.7±14.8 years ranging 
from 16 to 86. Sex ratio was 1.23. Two groups of patients were identi¿ ed: 44 
(39%) with acute sero¿ brinous pericarditis and 70 (61%) with moderate to 
large pericardial effusion. The most frequent symptom was dyspnea (69%) 
and the most common ECG ¿ nding was tachycardia (39%). From 54 patients 
with clinical tamponade, 92% showed collapse of one or more right cardiac 
chambers on echocardiography. 48 patients (89%) underwent pericardio-
centesis and 2 surgical drainage. In these 54 patients, cancers were the ¿ rst 
causes of pericardial effusion (46%) followed by viral, bacterial, or tubercu-
lous infections (17%). Idiopathic pericarditis was present in 33% of cases. 
Patients with sero¿ brinous pericarditis were signi¿ cantly younger (52.5±13.6 
vs 60.9±14.7 years; p<0.01) compared with those with pericardial effusion 
without cancer.
Conclusion: In our retrospective study, cancers were the most frequent 
causes of pericardial effusion whereas the majority of sero¿ brinous pericarditis 
were idiopathics. Incidence of pericardial effusion was associated with advanced 
age whereas sero¿ brinous pericarditis was more frequent in younger patients.
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Value of real-time three-dimensional echocardiography to select pa-
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Hugo Brahic [Orateur], Yannick Saludas, Hassan Mansour, Aime Amonchot, 
Bernard Citron
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Background: Cardiac resynchronization therapy (CRT) is an established 
therapy for patients with advanced heart failure and wide QRS complex. 
However, a large number of patients do not respond to CRT.
Aims: To assess the value of real-time three-dimensional echocardiography 
(RT3DE) to predict response to CRT.
Methods: Patients with standard CRT indications were enrolled. Patients 
with three-dimensional asynchrony (systolic dyssynchrony index (SDI)>8%) 
have a potentially good response to CRT and they underwent activated resyn-
chronization therapy (CRT ON). For other patients (SDI<8%), the response 
to CRT is much more uncertain and they were randomly assigned to an acti-
vated resynchronization group (CRT ON) or to a non activated resynchroni-
zation group (CRT OFF). Clinical and echocardiographic assessments were 
performed at baseline and 3 and 6 months after device implantation.
Results:  Eighteen patients were enrolled and followed for 6 months. Three 
patients were excluded from the statistical analysis because of incomplete 
data.  All patients in CRT ON (n=11) had improved exercise tolerance (New York 
Heart Association (NYHA) functional class: - 1.55 vs - 0.5 (p=0.045), peak VO2: 
+35 vs +14%), quality of life (+71 vs +27%) and left ventricular function (+46 vs 
0%). Patients with three-dimensional asynchrony (SDI > 8%) had greater impro-
vement after CRT than patients with SDI<8% (NYHA: -1.6 vs – 1.5, quality of 
life: +85 vs 58%, left ventricular ejection fraction: +67 vs 15%).  
Conclusion:  Cardiac resynchronization results in signi¿ cant clinical and 
echocardiographic improvement in patients who have severe heart failure and 
intraventricular delay.  In addition, RT3DE seems to be highly predictive for 
acute response to CRT. 
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Contribution of Internal Loop Recorder in patients with a supposed 
risk of ventricular arrhythmia and a Brugada Syndrome
Linda Aissou [Orateur], Sarah Traulle, Maciej Kubala, Anne-Lise Piriou, 
Jean-Sylvain Hermida
CHU Amiens Sud, Cardiologie A, Amiens, France
Background: Implantable cardioverter de¿ brillator is used in patients 
with Brugada Syndrome who have an antecedent of typical syncope or an 
antecedent of sustained ventricular tachycardia or ¿ brillation. Risk strati¿ ca-
tion of ventricular arrhythmias is a dif¿ cult step in patients without symptoms 
or with atypical symptoms.
Implantable loop recorder (ILR) is proposed to study patients with unex-
plained recurrent syncopal events, but its utility and safety remains to de¿ ne 
in patients with Brugada syndrome.
Objectives: The goal of this retrospective study was to evaluate the contri-
bution of implantable loop recorder in diagnostic of atypical symptoms or in 
asymptomatic patients with a supposed risk of ventricular arrhythmia.
Methods: Among a register of 204 patients with Brugada Syndrome, 11 
patients: 3 women and 8 men, with a mean age of 44 years, received an 
implantable loop recorder between 2001 and 2010 for atypical syncope or for 
supposed risk of ventricular arrhythmia (a patient with a family history of 
sudden cardiac death, and a patient with a positive programmed electrical sti-
mulation, in spite of a treatment with hydroquinidine).
Results: Average time ILR implant was 33 months. Eight patients among 
9 symptomatic patients had a recurrence of symptoms with a mean time of 
9 [+/-13] months after ILR implantation. Recurrence of symptoms occurs in 
3/9 patients (33%) after 3 months, in 6/9 patients (66%) after 6 months, and in 
7/9 patients (77%) after 12 months. Bradycardia was detected in 4/8 patients 
(50%), and there was no ventricular arrhythmia in any patients during symp-
tomatic events. In the 2 asymptomatic patients, there was neither symptomatic 
nor rhythmic event during the 2 and 3 years of implantation. Supraventricular 
tachycardia was diagnosed in 3/11 patients (27%).
Conclusion: The ILR contributed to establish the mechanism of atypical 
syncope in the majority of patients with electrocardiographic Brugada syn-
drome. It allows a continual monitoring in patients with a supposed risk of 
ventricular arrhythmias during many years. It may delay the insertion of car-
dioverter de¿ brillator in patients who have experienced an atypical syncope 
without documentation of ventricular arrhythmia. 
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Etiology and clinical features of pericarditis: data from a single tertiary 
cardiac center in Romania
Adela RoúIanu [Orateur], Horia RoúIanu, Ruxandra Beyer, Paula Varga, 
Radu CăPâlneanu
Heart Institute “Niculae Stăncioiu” Cluj-Napoca, Romania, Cluj-Napoca, 
Roumanie
Introduction: Pericarditis has a low prevalence in the general population 
and accounts for approximately 5% of the ¿ nal diagnosis in patients with non-
anginal chest pain. Because acute pericarditis is frequently clinically silent and 
self-limiting, epidemiological data on its incidence are lacking.
Objectives: The purpose of this study was to evaluate the epidemiological 
and clinical features of patients with pericarditis and pericardial effusions with 
or without subsequent tamponade, and to determine the incidence of etiolo-
gical types.
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admitted for heart failure and with a preserved LVEF. These observations help 
clarifying persisting uncertainties regarding diastolic and systolic function in 
HFPEF and may help in selecting therapy for such patients.
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Aim: The aim of this study is to assess in a rat experimental model the pro-
nostic value of a non invasive mesuare of left ventricular diastolic pressure and 
diastolic dysfunction with echocardiographic indexes in a model of heart failure. 
The experimental model will be done by clipping the transverse aortic cross 
(TAC) in 24 Wistar rats to obtained a pressure overload from the 15 days to 
the 90 days, operated rats were compared with sham animals during the study.
Methods:  All the rats measurement protocole will be done under anasthesia 
(4mg/100g body weight ).To accurately identi¿ ed rats with the left ventricular 
¿ lling pressures and diastolic dysfunction four measurement will be done with 
echocardiographic indexes, the ratio of early transmitral velocity À ow (E)  to 
early septal mitral annulus velocity À ow (Ea) the exit mitral annulus diameter 
(D) the duration of E wave(t), the mean blood À ow time average (U) the S 
annulus wave in DTI and also the Time Vortex Formation T= t X U /D and left 
ventricular relaxation time.Also the systolic parameters function were studied 
(LVEF, ventricular diameters cardiac output ) 
Statistical analysis: Data will be expressed as mean +/- SEM, the statis-
tical analysis will be performed with the student’s ttest for paired ans unpaired 
variates.
Results: Diastolic dysfunction parameters were observed at 14 days in rats 
operated ans also at 90 days with a interaction between the time and the group;
• Left atrial diamater (6.37 mm +/- 0.82 vs 3.9 mm +/- 0.18; p<0.005).
• Left atrial surface (55 mm2 +/- 2.34 vs 20.1 mm2 +/- 2.04; p<0.005).
• S velocity wave(0.002 m/s +/- 0.004 vs 0.0043 m/s +/- 0.0006; p=0.05)
• Diameter annulus mitral (7.26 mm +/- 147 vs 3,81 mm +/- 0.57; p=0.005)
• Time Vortex Formation (2,60 +/- 0,57 vs 3,81 +/- 0.37; p=0.03)
• TRIVG (22,5 ms +/- 1.52 vs 19.3 ms +/- 1.02; p<0.005)
• Cardiac output (115ml/mn +/- 12 vs 185 ml/mn +/- 10; p<0.005)
In this work we test the hypothesis that the process ring formation during 
early diastolic ventricular dysfunction affects cardiac health as a index of mor-
tality like previously clinical parameters observed in human  
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Trabecular fate mapping using a Cx40-CreERT2 mouse line during left 
ventricular non-compaction
Lucile Miquerol [Orateur], Sabrina Beyer, Robert Kelly
IBDML CNRS 6216, Marseille Cedex 09, France
Left ventricular non-compaction (LVNC), very often found in neuromus-
cular disorders, can be considered like a third form of congenital cardio-
myopathy. This is a rare and severe form of cardiomyopathy, associated with 
extensive ventricular trabeculae.
During cardiac development, invaginations of the myocardium, termed 
trabeculae, appeared at the endocardial surface of the ventricles. Trabeculation 
is an essential step for generating a functionally competent ventricular wall. 
The trabeculae are transitional structures, and their disappearance coin-
cides with a step of compaction, which forms a compact myocardial wall. 
Trabeculae are also considered to be precursors of Purkinje ¿ bers (PF). The 
PF represent the peripheral network of the ventricular conduction system, 
which is responsible for the rapid propagation of electrical activity in the ven-
tricles to coordinate heartbeats.
The ¿ rst aim of this study was to de¿ ne the fate of trabeculae during 
normal heart development. We investigated whether trabeculae give rise to 
Myocardial involvement in Friedreich’s Ataxia (FA) is characterized by 
iron deposits, ¿ brosis and necrosis. We hypothesized that subclinical left 
ventricular (LV) dysfunction might occur in patients with who present with 
normal LV ejection fraction (LVEF) and mass.
Methods: Nineteen patients who were homozygous for the GAA expan-
sion in the FA gene (mean age: 35±16 years) and nineteen age- and gender 
-matched controls (35±15 years) were submitted to standard echocardio-
graphy. Short axis basal and apical views were analyzed using speckle trac-
king. LV twist was de¿ ned as the net difference between the apical and basal 
rotation. Peak systolic LV longitudinal strain was calculated from the apical 
2-,3- and 4-chamber views.
Results: The two groups did not differ in terms of LVEF (68±6% and 
66±6% in patients and in controls, respectively). A slightly higher LV mass 
index was observed in the patient group (93±19 g/m² versus 81±17 g/
m², p=NS). The LV ¿ lling parameters did not differ between the 2 groups. 
However, early diastolic mitral annular velocity (Ea) was lower and the ratio 
of early transmitral À ow velocity to Ea was higher in FA patients (table). Peak 
LV twist and global systolic longitudinal strain (GSLS) were signi¿ cantly 
reduced in patients as compared to controls. Early diastolic LV untwisting (at 
5%, 10% and 15% of diastole) was not signi¿ cantly different.
Conclusions: In patients with FA and normal LVEF and mass, the detec-
tion of an alteration in LV twist and GSLS suggests the presence of subclinical 
myocardial dysfunction. These parameters may prove useful as an outcome 
measure for the assessment and follow-up of new therapies in the early stages 
of the disease.
Friedreich 
patients (n=19)        
Controls    
(n=19) 
P value
E wave velocity (cm/s) 72±13 81±17 NS
E/A 1.6±0.6 2.1±0.7 NS
Ea (cm/s) 8.9±2.0 12.9±3.2 0.000
E/Ea 8.7±2.3 6.6±1.6 0.002
Peak LV twist (°) 9.3±3.4 11.7±2.3 0.015
GSLS (%) -15.3±2.2 -17.5±1.6 0.001
Values are means±SD
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Christophe Thébault (1), Erwan Donal [Orateur] (1), Frederic Schnell (1), 
Elodie Drouet (2), Emilie Nonotte (2), Jean-Claude Daubert (1)
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Background: Heart failure (HF) with a preserved (P) left ventricular (LV) 
ejection fraction (EF) is common, though its diagnosis and physiopathology 
remain unclear. We sought to compare the myocardial characteristics at rest 
and during submaximal exercise in patients with HFPEF and in controls.
Methods: Standardized submaximal exercise stress echocardiography was 
performed in a) 36 patients from the KaRen HFPEF-registry, whose LV EF 
was  45%, and b) 10 control patients free from manifestations of HF.
Results: During submaximal exercise LV-systolic function measured as 
global 4-chamber longitudinal strain was -17.2±4.7% in patients with HFPEF 
versus -23.7±3.1% in controls (p<0.001), LV longitudinal diastolic function, 
expressed as e’ was 9.9±2.8 cm/s in patients, versus 14.5±3 cm/s in controls 
(p<0.001), and RV longitudinal systolic function, expressed as RV s’, was 
13.3±3.5 cm/s in patients versus 17.7±1.5 cm/s in controls (p<0.05).  LV after-
load (arterial elastance was 2.6±1 mmHg/ml in patients versus 0.8±1.4 mmHg/
ml in controls; p<0.001) was signi¿ cantly higher in the HFPEF than in the 
control group, and was correlated with a decrease in LV longitudinal strain 
(R=0.63, p<0.001) during exercise.
Conclusion: Signi¿ cant abnormalities of LV-systolic and diastolic func-
tions were revealed by exercise stress echocardiography in patients recently 
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The Cardiovascular Assessment Facility – Experimental Microsurgery 
Facility (CAF-EMIF) is a core facility of the University of Lausanne, esta-
blished to offer services for researchers in the cardiovascular ¿ eld. The facility 
aims at providing sophisticated techniques to the scienti¿ c community for the 
physiological assessment of the cardiovascular system in rodents. Speci¿ cally, 
the CAF-EMIF provides investigators with the latest equipment for cardio-
vascular imaging, in particular a high-resolution ultrasound system allowing 
determination of cardiac performance and dimensions. The CAF-EMIF is also 
equipped for the measurement of hemodynamic parameters. In addition, the 
CAF-EMIF offers a microsurgery service for producing pathophysiological 
models. Scienti¿ c support is provided for the design of experimental proto-
cols as well as for the development of new techniques for the investigation of 
the cardiovascular system.
Services:
Echography (Vevo770, Visualsonics): Left ventricular function and dimen-
sions; Doppler tracing; Assessment of organ perfusion; abdominal echo-
graphy; following of tumor growth.
Electrocardiography (EMKA): Detailed analysis of ECG complexes; 
Arrhythmias.
Blood pressure and heart rate measurements (Visitech, Notocord & DSI): 
Noninvasive method by Tail-cuff recordings; Invasive method by direct arte-
rial measurements; Long term measurement by telemetry.
Pathophysiological models: Myocardial infarction; Transaortic constric-
tion (pressure overload model); Goldblatt renovascular hypertension models 
(1K1C; 2K1C); Carotid balloon injury.
Microsurgical Services: Vascular catheterization; implantation of osmotic 
minipump; Myocardial cell injection; etc.
contractile cardiomyocytes as well as PF, using a novel transgenic mouse 
line (Cx40KI-CreERT2-RFP) expressing the tamoxifen-inducible Cre recom-
binase speci¿ cally in the trabeculae and developing VCS. The Connexin-40 
(Cx-40) gene encodes a gap junction protein speci¿ cally expressed 
throughout the development of the VCS. The RFP reporter gene is expressed 
in the same tissues as described for the endogenous Cx40 gene during deve-
lopment. We carried out a prospective Cre lineage mapping by crossing the 
Cx40Cre/+ with R26R mice.
The second aim would be realized a lineage of the trabeculae in a mouse 
model of LVNC, using Nkx2.5+/- mutant. Nkx2.5+/- mice display disturbance 
of the VCS associated with severe hypoplasia of the PF and a persistence of 
trabeculae at the apex of the left ventricle. This lineage analysis will allow us 
to determine if this PF hypoplasia results in either a defect of PF recruitment 
or a defect of trabeculae differentiation in PF.
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The number of rodent genetic models of human diseases has dramatically 
increased over the past years. Studying the complex cardiovascular pheno-
types in these models requires standardized state-of-the-art techniques, and 
often calls for the development of new methods to investigate the cardiovas-
cular system.
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